Stockscreener 앱 받기
0.747
6.71%
0.047
Trinity Biotech Plc Adr 주식(TRIB)의 최신 뉴스
Trinity Biotech secures $25M equity financing facility - Investing.com
Trinity Biotech secures $25M equity financing facility By Investing.com - Investing.com South Africa
Trinity Biotech receives Nasdaq delisting warning notice - Investing.com
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares - GlobeNewswire Inc.
Trinity Biotech receives final approval for HIV test manufacturing shift - Investing.com South Africa
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification By Investing.com - Investing.com South Africa
Trinity Biotech receives final approval for HIV test manufacturing shift By Investing.com - Investing.com India
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification - Investing.com
Trinity Biotech plc (TRIB) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Trinity Biotech plc's (NASDAQ:TRIB) Share Price Boosted 54% But Its Business Prospects Need A Lift Too - Sahm
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Dow Gains 100 Points; US Durable Goods Orders Decline In October - Benzinga
TRIB: Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty - TradingView — Track All Markets
TRIB: Gross margin rose to 45.2% and Adjusted EBITDA turned positive despite a $5.1m net loss - TradingView — Track All Markets
Trinity Biotech secures $5 million funding, extends credit agreement - Investing.com India
Trinity Biotech stock soars after major HIV test order signals market recovery By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech secures $5 million funding, extends credit agreement By Investing.com - Investing.com South Africa
Trinity Biotech receives 9 million unit order for HIV screening product - Investing.com
Trinity Biotech receives 9 million unit order for HIV screening product By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system - Investing.com
Trinity Biotech stock rises on expanded rollout of next-gen HbA1c system By Investing.com - Investing.com South Africa
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech plc (TRIB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Trinity Biotech receives WHO approval for outsourced HIV test manufacturing - Investing.com
Why You Need Trinity Biotech Plc ADR (TRIB) On Your Watchlist - fostersleader.com
Operating cash flow per share of Trinity Biotech Plc Sponsored ADR Class A – LS:A404JF - TradingView
EBIT per share of Trinity Biotech plc ADR – MUN:TRB0 - TradingView
Top investors say Banco Macro S.A. ADR (BMA) ticks everything they need - Setenews
Trinity Biotech : 2025 AGM Notice Sent to holders of Ordinary Shares - MarketScreener
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
TRIB’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com
Trinity Biotech reports positive results for calibration-free CGM - Investing.com
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround - MarketScreener
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process - MarketScreener
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan - MarketScreener
Trinity Biotech plc Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV - MarketScreener
Trinity Biotech : Regains Compliance with Nasdaq Listing Requirements Form 6 K - MarketScreener
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform - MarketScreener
India Hba1c Testing Devices Market Size & Outlook, 2024-2030 - Grand View Research
Saudi Arabia Lyme Disease Testing Market Size & Outlook, 2030 - Grand View Research
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology - MarketScreener
Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer - MarketScreener
India Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
UK Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
Trinity Biotech names new Chief Commercial Officer By Investing.com - Investing.com UK
Trinity Biotech appoints new biosensor marketing director - Investing.com
Trinity Biotech plc Announces Chief Financial Officer Changes - MarketScreener
Trinity Biotech (TRIB) Stock Forecast and Price Target 2026 $TRIB - MarketBeat
Trinity Biotech Announces the Appointment of Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development - MarketScreener
symbol__ Stock Quote Price and Forecast - CNN
Trinity Biotech plc Share Price ADR Each Representing 20 Ord Shares SPON - Hargreaves Lansdown
Trinity Biotech announces ADS ratio change - Investing.com
Trinity Biotech Plc Sponsored ADR Class A Earnings and Revenue – NASDAQ:TRIB - TradingView — Track All Markets
1.81%
자본화:
|
볼륨(24시간):